Suppr超能文献

头颈部皮肤血管肉瘤的治疗模式和生存情况。

Patterns of Care and Survival of Cutaneous Angiosarcoma of the Head and Neck.

机构信息

New York University Langone Health, New York, New York, USA.

出版信息

Otolaryngol Head Neck Surg. 2020 Jun;162(6):881-887. doi: 10.1177/0194599820905495. Epub 2020 Feb 11.

Abstract

OBJECTIVE

To analyze the patterns of care and survival of cutaneous angiosarcomas of the head and neck.

STUDY DESIGN

Retrospective cohort study.

SETTING

National Cancer Database.

METHODS

The National Cancer Database was queried to select patients with cutaneous angiosarcoma of the head and neck between 2004 and 2015. For survival analysis, patients were included only if they received definitive treatment and complete data. Prognostic factors were analyzed by univariate and multivariable Cox regression.

RESULTS

We identified 693 patients diagnosed with head and neck angiosarcomas during the study period. The majority were male (n = 489, 70.6%) and elderly (median, 77 years). A total of 421 patients (60.8%) met the criteria for survival analyses. These patients were treated with surgery and radiation (n = 178, 42.3%), surgery alone (n = 138, 32.8%), triple-modality therapy (n = 48, 11.4%), surgery and chemotherapy (n = 29, 6.9%), and chemoradiation (n = 28, 6.7%). With a median follow-up of 29 months, the 3-year survival was 50.1%. Patients undergoing surgery had better median survival than those who did not (38.1 vs 21.0 months, = .04). Age, comorbidity, tumor size, and surgical margins were significant factors in univariate analyses. On multivariable analysis, age ≥75 years (hazard ratio, 2.65; 95% CI, 1.80-3.88; < .001) and positive margins (hazard ratio, 1.91; 95% CI, 1.44-2.51; < .001) predicted worse overall survival.

CONCLUSION

Angiosarcoma of head and neck is a rare malignancy that affects the elderly. Surgical treatment with negative margins is associated with improved survival. Even with curative-intent multimodality treatment, the survival of patients aged ≥75 years is limited.

摘要

目的

分析头颈部皮肤血管肉瘤的治疗模式和生存情况。

研究设计

回顾性队列研究。

设置

国家癌症数据库。

方法

国家癌症数据库查询 2004 年至 2015 年间头颈部皮肤血管肉瘤患者。对于生存分析,仅纳入接受确定性治疗且资料完整的患者。采用单因素和多因素 Cox 回归分析预后因素。

结果

研究期间共确定 693 例头颈部血管肉瘤患者。大多数为男性(n = 489,70.6%)和老年人(中位年龄,77 岁)。共有 421 例(60.8%)符合生存分析标准。这些患者接受了手术和放疗(n = 178,42.3%)、单纯手术(n = 138,32.8%)、三联疗法(n = 48,11.4%)、手术和化疗(n = 29,6.9%)以及放化疗(n = 28,6.7%)。中位随访 29 个月,3 年生存率为 50.1%。接受手术的患者中位生存时间优于未手术患者(38.1 个月比 21.0 个月,P =.04)。年龄、合并症、肿瘤大小和手术切缘是单因素分析中的显著因素。多因素分析显示,年龄≥75 岁(风险比,2.65;95%可信区间,1.80-3.88;P <.001)和阳性切缘(风险比,1.91;95%可信区间,1.44-2.51;P <.001)预示着总体生存更差。

结论

头颈部血管肉瘤是一种罕见的恶性肿瘤,好发于老年人。阴性切缘的手术治疗与生存改善相关。即使采用根治性多模态治疗,≥75 岁患者的生存仍受到限制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验